Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Fetal growth restriction (FGR) is the second leading contributor to perinatal mortality after prematurity [1]. The incidence is between 3-10% in developed countries, which increases to approximately 20% in developing countries [2]. FGR neonates have an increased perinatal and infant mortality and are more prone to cardiovascular disease, obesity and diabetes in adulthood [3]. There are multiple maternal, fetal and placental disorders that affect fetal growth. The known causes are poor maternal nutrition, hypertensive disorders complicating pregnancy, maternal medical disorders (multiple pregnancy, congenital fetal malformations), and lifestyle influences [4]. However, in vast majority of cases, the cause still remains unknown. Recent literature suggests the role of increased redox imbalance as an ultimate step in etiology of these cases of idiopathic origin [5,6].